01:10:15 EDT Tue 17 Sep 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.52.31·2.368.82.33-0.40-14.7270.76034382.49  2.59  2.123.39  1.4415:59:5915:3115 min RT 2¢
TSX - T0.52.31·2.368.82.33-0.40-14.7136.03032422.49  2.49  2.123.39  1.4415:59:4715 min
NEO ATS - U 2.29-0.44-16.121.749162.46  2.46  2.2012:44:0315 min
Alpha - A 2.34-0.39-14.379.1179342.39  2.40  2.1215:53:0515 min
Omega - O 2.30-0.43-15.81.0212.30  2.30  2.3012:44:0315 min
Pure - P 2.33-0.40-14.77.115342.59  2.59  2.1515:16:1115 min
Chi-X - X 2.33-0.40-14.77.01582.41  2.41  2.1515:59:5915 min
CX2 - H 2.35-0.38-13.911.725432.39  2.42  2.1913:46:0615 min
CXD - D 2.34-0.39-14.32.34252.41  2.48  2.1315:52:1315 min
TriAct - M 2.734.7935    Sep 11-2015 min

Recent Trades - Last 10 of 438
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59X2.33-0.401001 Anonymous79 CIBCK
15:59:47T2.33-0.4010014 Virtu ITG79 CIBCK
15:59:32T2.33-0.4010014 Virtu ITG79 CIBCK
15:59:32T2.34-0.3910079 CIBC79 CIBCK
15:55:06T2.35-0.381,50080 National Bank1 AnonymousK
15:53:05A2.34-0.391,80079 CIBC1 AnonymousK
15:53:05T2.34-0.391007 TD Sec1 AnonymousK
15:53:05T2.34-0.3910053 Morgan Stanley1 AnonymousK
15:52:42A2.34-0.3910079 CIBC80 National BankK
15:52:42D2.33-0.403080 National Bank80 National BankE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-09-16 15:31C:MDP2.33News ReleaseMedexus's Treosulfan NDA review extended by FDA
2024-08-23 06:57C:MDP2.41In the NewsGlobe says Medexus Pharmaceuticals maintained at "buy"
2024-08-14 09:02C:MDP2.49In the NewsGlobe says Treosulfan could double Medexus's sales
2024-08-07 18:51C:MDP2.27SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-08-07 18:51C:MDP2.27SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-07 17:43C:MDP2.27News ReleaseMedexus Announces Strong Fiscal Q1 2025 Results
2024-07-30 17:48C:MDP2.34News ReleaseMedexus Pharmaceuticals to release Q1 results Aug. 7
2024-06-25 19:06C:MDP1.69SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-25 18:56C:MDP1.69News ReleaseMedexus loses $200,000 (U.S.) in fiscal 2024
2024-06-25 18:49C:MDP1.69SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-25 18:49C:MDP1.69SEDAR MD & ASEDAR MD & A
2024-06-18 17:15C:MDP1.63News ReleaseMedexus to release fiscal 2024 results June 25
2024-06-06 10:35C:MDP1.62News ReleaseMedexus's treosulfan NDA resubmission accepted by FDA
2024-06-06 10:26C:MDP1.62Resume TradingMedexus Pharmaceuticals to resume at 8 a.m. PT
2024-06-06 10:05C:MDP1.62Halt TradingMedexus Pharmaceuticals halted at 7:04 a.m. PT
2024-05-01 17:47C:MDP1.75News ReleaseMedexus's Metoject patent no longer in effect in Canada
2024-03-26 12:03C:MDP1.70News ReleaseMedexus gets Ixinity supplemental biologics licence OK
2024-02-07 19:36C:MDP2.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-07 19:36C:MDP2.70SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-07 18:09C:MDP2.70News ReleaseMedexus loses $500,000 (U.S.) in fiscal Q3 2024